Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medipharm Labs Corp (OP:MEDIF)

0.0620 -0.0030 (-4.62%)
Streaming Delayed Price Updated: 1:59 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 62,430
Open 0.0616
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0650
Today's Range 0.0583 - 0.0632
52wk Range 0.0374 - 0.0850
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
Shareholders Urged to Vote for Proven Strategy and Team, Reject Dissident’s Inadequate Plan and Nominees 
From MediPharm Labs Corp.
Via GlobeNewswire

Performance

YTD
+45.5%
+45.5%
1 Month
-11.4%
-11.4%
3 Month
+18.1%
+18.1%
6 Month
+34.5%
+34.5%
1 Year
+11.7%
+11.7%

More News

Read More
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q2 2024
Via InvestorPlace
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
From MediPharm Labs Corp.
Via GlobeNewswire
Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis Company
From Apollo Technology Capital Corporation
Via GlobeNewswire
This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago
Via Benzinga
Topics Cannabis
Exposures Cannabis
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
From MediPharm Labs Corp.
Via GlobeNewswire
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
From MediPharm Labs Corp.
Via GlobeNewswire
Alleged Securities Fraud at MediPharm Labs Says Apollo Capital
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
From MediPharm Labs Corp.
Via GlobeNewswire
Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck’s Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
From MediPharm Labs Corp.
Via GlobeNewswire
Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
From MediPharm Labs Corp.
Via GlobeNewswire
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
Via Benzinga
Topics Government
Exposures Political
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
Via Benzinga
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report- Monday, Aug 12
Via Talk Markets
Topics Cannabis
Exposures Cannabis
This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now
Via Benzinga
Topics Cannabis
Exposures Cannabis
Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Via Benzinga
Topics Cannabis
Exposures Cannabis

Frequently Asked Questions

Is Medipharm Labs Corp publicly traded?
Yes, Medipharm Labs Corp is publicly traded.
What exchange does Medipharm Labs Corp trade on?
Medipharm Labs Corp trades on the OTC Traded
What is the ticker symbol for Medipharm Labs Corp?
The ticker symbol for Medipharm Labs Corp is MEDIF on the OTC Traded
What is the current price of Medipharm Labs Corp?
The current price of Medipharm Labs Corp is 0.0620
When was Medipharm Labs Corp last traded?
The last trade of Medipharm Labs Corp was at 06/13/25 01:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.